GCAC and THINGBLU to Offer Cannabis & Hemp Growers Ability to Add Grower Business Intelligence Data to the Blockchain

Partnership part of Company’s 2022 ESG based Supply Chain technology initiative

Vancouver, British Columbia, Canada, May 10, 2022 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announce that ThingBlu, Inc.  (“TB”) will be partnering to help clients capture “Harvesting Insights” in the Efixii software platform and the new “clearESG” to enable growers and manufacturers to document the environment product was grown in and material tasks completed for full transparency on the blockchain.

ThingBlu, based in Kirkland WA, is a cloud-based platform solution that provides Workflow Management and Data Management tools that offers owners & managers’ operational visibility and control. Visibility of all employee tasks, associated data generated, as well as the ability to communicate and share this data with other systems.  ThingBlu BI data will allow growers to share on the blockchain data such as nutrients used, avg temp and humidity and plant inspections tasks to add in the transparency.

CEO Bradley Moore stated “Blockchain continues to provide a platform where companies like ThingBlu’s clients can share additional information with the consumer that evidenced their commitment to quality. In addition, the new Efixii “clearESG” product will help provide evidence of certifications and the steps taken to ensure compliance by the grower’s workforce”.  

Kevin Gorman, Founder and CEO of ThingBlu Inc. noted, “From the first time I met the GCAC team in Las Vegas in October 2021, I could see the impact of the eco-system GCAC was creating for supply chain management and ESG (Environment, Social and Governance) reporting. Transparency starts with the employees and the detailed information of the steps they take, that are often not seen by the consumer, that make a huge impact in the final product. Watering schedules, temperature and insect control, eyeballing every plant on a regular basis all are critical steps in delivering a beautiful living final product.”

Efixii is licensed to cultivators in a SaaS model and is a free-to-use app for cannabis consumers. All cannabis sold through the Portal generates a new sales-commission revenue stream for GCAC. Efixii’s cannabis data is the intellectual property (“IP”) of GCAC. This IP creates an inherent difficulty in replicating or competing with GCAC’s cannabis datasets. GCAC defined their protocols in a provisional U.S. patent application, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ filed with the USPTO on Dec. 17, 2020.

About ThingBlu Inc.

ThingBlu’s Workflow Management gives the grower the power to assign, monitor, and manage all daily tasks. Creation of best business practices, and clearer operational visibility provide greater agility to make data informed decisions. Employees are more engaged, more efficient, reducing turnover. Tasks are monitored in real time, from any location, to ensure they performed according to set SOPs and in an efficient manner. More info at thingblu.com

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high-quality cannabis datasets that improve patient outcomes and become the world’s largest cannabis efficacy data provider.

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

 

Press Contact

 Phone: +1 (800) 409-5679

Email: info@cannappscorp.com

Forward-Looking Information 

This news release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

 

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry.

Contact details

Related topics

Receive exclusive news

Are you a journalist or do you work for a publication?
Sign up and request access to exclusive news.

Request access

Receive Global Cannabis Applications Corp. news on your RSS reader.

Or subscribe through Atom URL manually